Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 19

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 8
Chunk 19
---
 if and when a change in reportable
segments occurs in a future period, the Company will retrospectively recast prior-period segment disclosures to reflect the new segment
structure, presenting historical information on the same basis as then reported. Notwithstanding the foregoing, the Company provides the
entity-wide disclosures required by ASC 280, including information about products and services, geographic areas, and major customers.

Note
9 – Subsequent Events

Note payable, related party

On October 1, 2025, the Company repaid in full the
unsecured, on demand working capital loan from its Chief Executive Officer, which accrued interest at 3% per annum. The repayment consisted
of the outstanding principal balance of $146,432 and accrued but unpaid interest of $4,350, for an aggregate payment of $150,782. Following
the repayment, no amounts remained outstanding under the loan.

Standby
Equity Purchase Agreement and Pre-Paid Advance with YA II PN, Ltd. (Yorkville)

On
October 24, 2025, the Company entered into a Standby Equity Purchase Agreement (“SEPA”) and related Registration Rights Agreement
with YA II PN, Ltd. (“Yorkville”), providing the Company the right, but not the obligation, to sell up to $20.0 million of
common stock from time to time, subject to customary conditions, including an effective resale registration statement. Each advance is
limited to 100% of the prior 5-day average daily trading volume and priced at 97% of the lowest daily volume-weighted average price (“VWAP”)
over a 3-day pricing period (subject to customary exclusions/reductions and equitable adjustments). Issuances are subject to (i) a 4.99%
beneficial-ownership cap (increasable on 65 days’ notice) and (ii) a Nasdaq 19.99% cap of 7,180,504 shares (the “Exchange
Cap”) unless stockholder approval is obtained. The Company intends to seek such approval at its annual meeting scheduled for December
19, 2025.

In
connection with the SEPA, Yorkville agreed to provide up to $6.0 million of pre-paid advances via convertible promissory notes. On October
27, 2025, the Company received $3,720,000 and issued a $4.0 million note (7% original issue discount, “OID”). A second $1,860,000